Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Veeva Systems (VEEV) Q1 Earnings Top Estimates, View Strong

Published 05/30/2019, 08:19 AM
Updated 07/09/2023, 06:31 AM
XRAY
-
CNMD
-
MASI
-
VEEV
-

Veeva Systems Inc. (NYSE:VEEV) reported first-quarter fiscal 2020 earnings per share (EPS) of 50 cents, well ahead of the Zacks Consensus Estimate of 45 cents. The metric shot up 61.3% on a year-over-year basis.

This Zacks Rank #2 (Buy) company’s revenues totaled $244.8 million, outpacing the Zacks Consensus Estimate of $238.7 million. On a year-over-year basis, the top line improved 25.2%.

Segmental Details

Subscription Service

First-quarter subscription service revenues summed $198.1 million, up 27% year over year. Per management, the solid momentum in bookings was maintained in the quarter.

Professional Service and Others

Professional Service revenues rose almost 17.9% to $46.6 million from the figure registered in the year-ago quarter.

Per management, outperformance by Veeva Commercial Cloud and Veeva Vault drove revenues across all segments.

Veeva Systems Inc. Price, Consensus and EPS Surprise

Veeva Systems Inc. price-consensus-eps-surprise-chart | Veeva Systems Inc. Quote

Margin Details

In the reported quarter, adjusted gross profit increased 31.9% to $183.3 million. Adjusted gross margin was 74.9%, which expanded 380 basis points (bps).

Adjusted operating income totaled $93.5 million, up 48.5% year over year. In the quarter under review, adjusted operating margin improved 600 bps to 38.2%.

However, adjusted operating expenses rose 18.2% year over year to $89.8 million.

Guidance

For the fiscal second quarter, revenues are expected within $259 million and $260 million. The Zacks Consensus Estimate for the same is pegged at $250.4 million, below the projected range.

Adjusted EPS is anticipated within 48-49 cents. The Zacks Consensus Estimate is pegged at 47 cents, lower than the guided range.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Adjusted operating income is projected within $94-$95 million.

For fiscal 2020, Veeva Systems expects revenues in the band of $1,045-$1,050 million. The Zacks Consensus Estimate for the same is pinned at $1,030 million, below the guided range.

Adjusted full-year EPS is expected within $2.01 and $2.03. The Zacks Consensus Estimate for the same stands at $1.94, much below the guided range.

Adjusted operating income is projected within $385 million and $390 million.

Wrapping Up

Veeva Systems ended the fiscal first quarter on a strong note, wherein earnings and revenues outpaced the Zacks Consensus Estimate. Also, the Subscription business segment performed impressively in the quarter. An impressive guidance for fiscal 2020 buoys optimism in the stock.

These apart, the company continues to benefit from its flagship Vault platform. In fact, Veeva Vault’s customers have increased manifold in recent times. Markedly, Veeva Systems’ unique solutions include Veeva Vault, Veeva CRM, Veeva Network and Veeva OpenData. The company’s new CRM Sunrise UI and Nitro look promising as well. In Commercial Cloud, Veeva Systems has secured a number of deals. The company is confident about growth in new markets with products like EDC, Safety, Nitro and Vault.

On the flip side, high expenses on the operational side are worrisome. Also, intense competition and a saturating life sciences market remain potent threats. Volatility in the foreign currency exchange rate is an added concern.

Earnings of MedTech Majors at a Glance

A few other top-ranked stocks which reported solid results this earning season are Masimo Corporation (NASDAQ:MASI) , DENTSPLY SIRONA Inc. (NASDAQ:XRAY) and CONMED Corporation (NASDAQ:CNMD) . You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Masimo reported first-quarter 2019 adjusted EPS of 79 cents, which surpassed the Zacks Consensus Estimate of 75 cents. The company’s revenues improved 8.8% year over year to $231.7 million and edged past the Zacks Consensus Estimate of $223.6 million. The company carries a Zacks Rank of 2.

DENTSPLY reported adjusted EPS of 49 cents in the first quarter of 2019, beating the Zacks Consensus Estimate of 38 cents. Revenues came in at $946.2 million and surpassed the Zacks Consensus Estimate of $917.1 million. The company carries a Zacks Rank #2.

CONMED posted first-quarter 2019 adjusted EPS of 57 cents, which beat the Zacks Consensus Estimate of 54 cents. Revenues were $218.4 million, surpassing the Zacks Consensus Estimate of $213 million. The company sports a Zacks Rank of 1.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>



Veeva Systems Inc. (VEEV): Free Stock Analysis Report

Masimo Corporation (MASI): Free Stock Analysis Report

DENTSPLY SIRONA Inc. (XRAY): Free Stock Analysis Report

CONMED Corporation (CNMD): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.